Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04929444
Other study ID # 4R21/003
Secondary ID PI19/00736
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date December 31, 2022

Study information

Verified date May 2021
Source Jordi Gol i Gurina Foundation
Contact Eva Peguero, MD. PHD
Phone #34630053772
Email pegueroeva@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objectives: To verify the effectiveness of a blended course in PC to improve adherence to clinical practice guidelines. Design: randomized community trial, by clusters (control group -CG- / intervention group -IG-) Scope: 20 PCT (primary care teams)(10 per group) Outcome variables will be: Diagnostic records (proportion of nonspecific diagnoses such as dizziness and vertigo, with respect to specific diagnoses such as BPPV, vestibular neuritis); Derivations to otorhinolaryngologist (ENT) and neurologist; Prescription of antivertiginous medications and Number of days off work caused by vertigo-related. Statistical analysis:Descriptive statistics of all the baseline variables will be carried out and, the differences between groups in the post-intervention outcome variables will be evaluated through the t-test. In the IG, a multivariate logistic regression model will identify response patterns based on the baseline variables of professionals and centers


Description:

Vertigo is a prevalent pathology whose most frequent cause is benign paroxysmal positional vertigo (BPPV). Treatment of this disease are the relocation manoeuvres. Although these manoeuvres are effective in primary care (PC), they are not done routinely. Attention to other causes of vertigo in PC also has a wide margin for improvement. Objectives: To verify the effectiveness of a blended course in PC to improve adherence to clinical practice guidelines. Design: randomized community trial, by clusters (CG / IG), multicenter and open, taking as unit of allocation the primary care team (PCT). The professionals of the PCT that are in IG would receive the training at the beginning of the study and those of the control group will be offered after the conclusion of the same. Scope: 20 PCT (10 per group) selected from the "Costa de Ponent" Primary Care Directorate of the Catalan Health Institute. Variables: The outcome variables will be: Diagnostic records (proportion of nonspecific diagnoses such as dizziness and vertigo, with respect to specific diagnoses such as BPPV, vestibular neuritis); Derivations to otorhinolaryngologist (ENT) and neurologist; Prescription of antivertiginous medications and Number of days off work caused by vertigo-related illnesses during the study period. Other study variables will be characteristics of the professionals (age, sex) and centers (teachers, number of tutors, rural / urban). All the variables will be collected in an aggregated form by computerized data download during the year following the training intervention in the PCT. Statistical analysis: Following the CONSORT Cluster Guide, the baseline comparability of the two study groups will be analyzed to analyze the homogeneity. Descriptive statistics of all the baseline variables will be carried out and, the differences between groups in the post-intervention outcome variables will be evaluated through the t-test. In the IG, a multivariate logistic regression model will identify response patterns based on the baseline variables of professionals and centers. Conclusions: Positive results of the study could imply a paradigm shift in the approach to vertigo in primary care, which would be easy to extend to other areas since the most important part of the training course will be done online.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date December 31, 2022
Est. primary completion date September 1, 2021
Accepts healthy volunteers No
Gender All
Age group 15 Years and older
Eligibility Inclusion Criteria: - 20 randomized primary care teams out of the 56 that make up the "Costa de Ponent" Primary Care Department that serve a population of 1.3 million people. Exclusion Criteria: - Primary care teams in which> 60% of their professionals have received a course on vertigo in the last 5 years will be excluded. - Primary care teams who are not interested in participating in the study will be excluded

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Training on vertigo
Online training on vertigo management in primary care with a face-to-face session. On the one hand, the course will contain theoretical content and clinical cases will be used as the methodology of the course, with feedback paths for each correct or incorrect answer from the students and videos recorded expressly for the course. In addition, there will be a face-to-face session where all participants must perform the diagnostic and therapeutic maneuvers proposed in the course, to evaluate the use of the training and also to standardize the way of doing them for the study

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Jordi Gol i Gurina Foundation Catalan Society of Family Medicine, Instituto de Salud Carlos III

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic records proportion of nonspecific diagnoses such as dizziness and vertigo, with respect to specific diagnoses such as BPPV, vestibular neuritis one year
Secondary Derivations to otorhinolaryngologist (ENT) and neurologist Number of referrals made during the study period one year
Secondary Prescription of antivertiginous medications Number of prescriptions of betahistine, sulpiride, dimenhydrinate made during the study period One year
Secondary Days off work Number of days off work caused by vertigo-related illnesses during the study period One year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed NCT02533739 - Vestibular Disorder and Visuo-spatial Functions N/A
Completed NCT01153789 - Study of Oculomotor Dysfunction Leading to Children Vertigo N/A
Completed NCT00765635 - Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal Phase 4
Not yet recruiting NCT04055766 - A Diagnostic Test on DeepDoc-an AI-based Decision Support System
Completed NCT04458376 - Internet-based Self-help Program for Vestibular Rehabilitation in Chronic Dizziness N/A
Recruiting NCT06332326 - Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients N/A
Completed NCT02938221 - Telemedical Examination of a Three-Component Oculomotor Testing Battery N/A
Active, not recruiting NCT02655575 - Assessment and Treatment of Patients With Long-term Dizziness in Primary Care N/A
Completed NCT02457455 - Urgent Medical and Surgical Conditions During Flights N/A
Enrolling by invitation NCT01426932 - The Head Impulse Test in the Screening of Vestibular Function N/A
Completed NCT00000359 - Treatments for Benign Paroxysmal Positional Vertigo (BPPV) Phase 2
Not yet recruiting NCT06010550 - Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
Not yet recruiting NCT06017466 - Translation and Implementation of the Dutch VVAS Score in Clinical Practice N/A
Completed NCT04598113 - Effect of Cervical Traction on Balance in Cervical Radiculopathy Patients N/A
Completed NCT05157399 - Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness N/A
Completed NCT05897853 - Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness
Completed NCT05221892 - Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo Phase 4
Completed NCT02253524 - Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo Phase 4